1. Home
  2. BDSX vs JHI Comparison

BDSX vs JHI Comparison

Compare BDSX & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$15.28

Market Cap

107.5M

Sector

Health Care

ML Signal

HOLD

Logo John Hancock Investors Trust

JHI

John Hancock Investors Trust

HOLD

Current Price

$13.38

Market Cap

116.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
JHI
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
107.5M
116.9M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
BDSX
JHI
Price
$15.28
$13.38
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
73.6K
16.7K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$88,499,000.00
N/A
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.25
$12.50
52 Week High
$20.21
$14.51

Technical Indicators

Market Signals
Indicator
BDSX
JHI
Relative Strength Index (RSI) 60.89 52.88
Support Level $12.77 $13.24
Resistance Level $16.26 $13.56
Average True Range (ATR) 1.22 0.10
MACD 0.61 -0.00
Stochastic Oscillator 86.52 41.27

Price Performance

Historical Comparison
BDSX
JHI

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About JHI John Hancock Investors Trust

John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others. The company's portfolio includes Corporate Bonds, Term Loans, U.S Government Agency, and Others.

Share on Social Networks: